FluoroPharma Medical, Inc.
FPMI · OTC
12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |
|---|---|---|---|---|
| Market Cap | $3,742 | $9,011 | $11,686 | $16,531 |
| - Cash | $25 | $291 | $252 | $1,143 |
| + Debt | $5,825 | $4,486 | $2,123 | $0 |
| Enterprise Value | $9,541 | $13,206 | $13,558 | $15,388 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$44 | -$46 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$744 | -$2,244 | -$3,984 | -$5,531 |
| % Margin | – | – | – | – |
| Net Income | -$2,050 | -$3,164 | -$5 | -$7 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.061 | -0.11 | -0 | -0 |
| % Growth | 44.5% | -54,900% | 33.3% | – |
| Operating Cash Flow | -$880 | -$2,677 | -$3,321 | -$3,332 |
| Capital Expenditures | -$1 | -$7 | -$357 | -$5 |
| Free Cash Flow | -$881 | -$2,684 | -$3,678 | -$3,337 |